Atomistry » Magnesium » PDB 3u8x-3ump » 3ui7
Atomistry »
  Magnesium »
    PDB 3u8x-3ump »
      3ui7 »

Magnesium in PDB 3ui7: Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia

Enzymatic activity of Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia

All present enzymatic activity of Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia:
3.1.4.17; 3.1.4.35;

Protein crystallography data

The structure of Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia, PDB code: 3ui7 was solved by S.Yang, J.Smotryski, W.Mcelroy, G.Ho, D.Tulshian, W.J.Greenlee, R.Hodgson, L.Xiao, A.Hruza, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 79.29 / 2.28
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 49.539, 81.611, 158.577, 90.00, 90.00, 90.00
R / Rfree (%) 19.5 / 24

Other elements in 3ui7:

The structure of Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia also contains other interesting chemical elements:

Zinc (Zn) 2 atoms

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia (pdb code 3ui7). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia, PDB code: 3ui7:
Jump to Magnesium binding site number: 1; 2;

Magnesium binding site 1 out of 2 in 3ui7

Go back to Magnesium Binding Sites List in 3ui7
Magnesium binding site 1 out of 2 in the Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg771

b:38.4
occ:1.00
 OD1 A:ASP564 1.9 43.0 1.0
O A:HOH30 1.9 22.7 1.0
O A:HOH29 2.0 31.9 1.0
O A:HOH10 2.1 21.9 1.0
O A:HOH25 2.2 43.7 1.0
CG A:ASP564 3.0 40.0 1.0
OD2 A:ASP564 3.4 32.8 1.0
ZN A:ZN772 3.7 39.8 1.0
OE2 A:GLU592 3.8 56.7 1.0
NE2 A:HIS595 4.0 54.7 1.0
O A:HIS563 4.1 44.5 1.0
CD2 A:HIS595 4.2 55.0 1.0
CD2 A:HIS563 4.2 40.7 1.0
CD2 A:HIS567 4.2 58.7 1.0
OG1 A:THR633 4.3 45.2 1.0
CB A:ASP564 4.3 38.8 1.0
O A:HOH773 4.4 26.7 1.0
O A:HOH31 4.4 29.8 1.0
NE2 A:HIS563 4.5 40.2 1.0
CD2 A:HIS525 4.6 49.5 1.0
NE2 A:HIS567 4.6 58.9 1.0
CA A:ASP564 4.6 38.9 1.0
OD2 A:ASP674 4.6 45.0 1.0
NE2 A:HIS525 4.7 49.5 1.0
CD A:GLU592 4.7 65.2 1.0
O A:THR633 4.8 40.4 1.0
CG A:GLU592 4.8 57.4 1.0
C A:HIS563 4.9 43.7 1.0
CB A:THR633 4.9 41.9 1.0

Magnesium binding site 2 out of 2 in 3ui7

Go back to Magnesium Binding Sites List in 3ui7
Magnesium binding site 2 out of 2 in the Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of Discovery of Orally Active Pyrazoloquinoline As A Potent PDE10 Inhibitor For the Management of Schizophrenia within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Mg771

b:28.8
occ:1.00
 O B:HOH112 2.0 36.5 1.0
OD1 B:ASP564 2.0 39.3 1.0
O B:HOH118 2.2 30.3 1.0
O B:HOH104 2.4 34.1 1.0
O B:HOH117 2.4 28.7 1.0
CG B:ASP564 3.0 42.3 1.0
OD2 B:ASP564 3.4 46.3 1.0
ZN B:ZN772 3.6 48.0 1.0
OE2 B:GLU592 3.7 69.9 1.0
NE2 B:HIS595 4.0 57.0 1.0
OG1 B:THR633 4.1 50.1 1.0
O B:HOH119 4.2 45.8 1.0
O B:HIS563 4.2 49.8 1.0
CD2 B:HIS563 4.2 45.6 1.0
CD2 B:HIS595 4.2 57.6 1.0
CB B:ASP564 4.3 44.0 1.0
O B:HOH109 4.5 32.0 1.0
NE2 B:HIS563 4.5 45.0 1.0
CD2 B:HIS567 4.5 54.0 1.0
O B:THR633 4.6 50.0 1.0
O B:HOH56 4.6 37.0 1.0
OD2 B:ASP674 4.6 54.5 1.0
CB B:THR633 4.7 50.8 1.0
NE2 B:HIS567 4.7 53.9 1.0
CA B:ASP564 4.7 44.1 1.0
CD2 B:HIS525 4.8 48.4 1.0
CD B:GLU592 4.8 79.1 1.0
O B:HOH100 4.9 44.5 1.0
NE2 B:HIS525 4.9 48.1 1.0
C B:HIS563 5.0 48.7 1.0

Reference:

S.W.Yang, J.Smotryski, W.T.Mcelroy, Z.Tan, G.Ho, D.Tulshian, W.J.Greenlee, M.Guzzi, X.Zhang, D.Mullins, L.Xiao, A.Hruza, T.M.Chan, D.Rindgen, C.Bleickardt, R.Hodgson. Discovery of Orally Active Pyrazoloquinolines As Potent PDE10 Inhibitors For the Management of Schizophrenia. Bioorg.Med.Chem.Lett. V. 22 235 2012.
ISSN: ISSN 0960-894X
PubMed: 22142545
DOI: 10.1016/J.BMCL.2011.11.023
Page generated: Mon Aug 11 04:13:40 2025

Last articles

Mn in 8ICO
Mn in 8ICP
Mn in 8HZM
Mn in 8ICK
Mn in 8ICN
Mn in 8I8T
Mn in 8I8S
Mn in 8I3O
Mn in 8I6V
Mn in 8HLF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy